|
|
Read Case Study I
| Weeks After Presentation |
Date of Lab
Test |
HIV/AIDS
Pateints |
Hemoglobin
(gl/dl) |
Platelet
Count |
White Cell
Count |
Percenage
Neutrophil |
Absolute
Neutrophil |
Percentage Lymphocyte |
Absolute
Lymphocyte |
Erthrocyte
Sedimentatation Rate |
Percentage monocyte |
Percentage
increase (Lymphocyte) |
|
| |
5/14/1999 |
A |
- |
103,000 |
2,700 |
|
|
|
|
|
|
|
| |
5/28/1999 |
|
11 |
136,000 |
2,800 |
67% |
|
20% |
560 |
|
7% |
|
| 4 |
6/16/1999 |
|
10 |
116,000 |
11,100 |
62% |
|
28% |
3080 |
|
3% |
|
| 5 |
6/23/1999 |
|
12.6 |
139,000 |
9,800 |
61% |
|
28% |
2744 |
|
4% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
start |
B |
10.8 |
152,000 |
2,400 |
62% |
|
25% |
600 |
|
3% |
|
| 4--5 |
|
|
11 |
155,000 |
2,450 |
60% |
|
27% |
662 |
|
8% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
8/6/2000 |
C |
10 |
|
5,800 |
62% |
|
36% |
2088 |
|
0% |
|
| 8 |
10/7/2000 |
|
10.5 |
|
5,200 |
45% |
|
53% |
2756 |
|
0% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
D |
9 |
160,000 |
2,600 |
60% |
|
38% |
988 |
|
0% |
|
| 4--5 |
|
|
14.7 |
200,000 |
5,000 |
57% |
|
38% |
1900 |
|
3% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
E |
12.6 |
138,000 |
3,750 |
63% |
|
29% |
1086 |
|
4% |
|
| 4--5 |
|
|
- |
|
3,900 |
59% |
|
35% |
1365 |
|
7% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
2/27/2001 |
F |
9.5 |
139,000 |
6,600 |
63% |
|
32% |
2112 |
65 |
2% |
|
| |
4/3/2001 |
|
10 |
|
5,000 |
45% |
|
52% |
2600 |
65 |
1% |
|
| |
4/18/2001 |
|
9 |
|
5,600 |
48% |
|
35% |
1960 |
74 |
3% |
|
| 12--13 |
5/29/2001 |
|
12.5 |
|
4,950 |
55% |
|
42% |
2079 |
31 |
2% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| * |
11/20/2000 |
G |
8 |
|
4,800 |
50% |
|
46% |
2208 |
- |
2% |
|
| 15 --
16 |
3/7/2001 |
|
10 |
|
4,950 |
49% |
|
45% |
2228 |
- |
3% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| * |
1/31/2001 |
H |
6.5 |
|
4,000 |
42% |
|
54% |
2160 |
86 |
4% |
|
| |
2/17/2001 |
|
8 |
|
6,700 |
46% |
|
50% |
3350 |
59 |
2% |
|
| 4--5 |
3/7/2001 |
|
9 |
|
|
60% |
|
34% |
|
43 |
4% |
|
| |
3/31/2001 |
|
9 |
|
5,000 |
45% |
|
50% |
2500 |
102 |
3% |
|
| |
4/13/2001 |
|
9.5 |
|
|
76% |
|
22% |
|
135 |
2% |
|
| Months After Presentation |
Date of
Lab Test |
HIV/AIDS
Pateints |
Hemoglobin
(gl/dl) |
Platelet
Count |
White Cell
Count |
Percenage
Neutrophil |
Absolute
Neutrophil |
Percentage Lymphocyte |
Absolute
Lymphocyte |
Percentage
increase (Lymphocyte) |
Erthrocyte
Sedimentatation Rate |
|
| |
6/8/2000 |
I |
10 |
- |
5,800 |
|
|
36% |
2088 |
|
|
| 1 |
7/10/2000 |
|
10.6 |
- |
5,200 |
|
|
53% |
2756 |
47% |
|
| 9 |
3/13/2001 |
|
12 |
- |
5,800 |
|
|
44% |
2552 |
22% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
10/13/1999 |
J |
12 |
108,000 |
2,100 |
62% |
1,302 |
26% |
546 |
|
|
| 9 |
7/12/2000 |
|
13.6 |
295,000 |
3,600 |
24% |
864 |
76% |
2,736 |
192% |
|
| 10 |
10/14/2000 |
|
12 |
189,000 |
4,200 |
44% |
1,848 |
54% |
2,268 |
107.70% |
|
| 13 |
5/18/2001 |
|
- |
|
3,900 |
30% |
|
62% |
|
138.50% |
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
8/7/2000 |
K |
10 |
141,000 |
3,200 |
42% |
|
52% |
1,664 |
|
134 |
| 2 |
10/12/2000 |
|
10 |
130,000 |
4,400 |
55% |
|
42% |
|
19% |
- |
| 4 |
12/18/2000 |
|
8.5 |
380,000 |
8,100 |
58% |
|
35% |
|
33% |
68 |
| 5 |
1/12/2001 |
|
9.6 |
165,000 |
4,800 |
50% |
|
44% |
|
15.30% |
45 |
| 6 |
2/12/2001 |
|
10 |
149,000 |
3,200 |
47% |
|
44% |
|
15.30% |
42 |
| 8 |
4/30/2001 |
|
10 |
149,000 |
3,200 |
33% |
|
65% |
2080 |
25% |
40 |
| 11 |
7/11/2001 |
|
12 |
165,000 |
3,200 |
50% |
|
48% |
|
|
- |
| |
|
|
|
|
|
|
|
|
|
|
|
| |
1/11/2001 |
L |
9.8 |
|
6,700 |
63% |
|
32% |
2144 |
|
79 |
| |
2/6/2001 |
|
8 |
|
5,000 |
60% |
|
34% |
|
|
48 |
| 3 |
3/3/2001 |
|
8.5 |
|
- |
|
|
|
|
|
10 |
| |
3/13/2001 |
|
9.5 |
|
4,000 |
49% |
|
48% |
|
|
- |
| 5 |
May-01 |
|
- |
|
6,600 |
50% |
|
44% |
|
|
12 |
| |
6/4/2001 |
|
9.5 |
|
6,600 |
50% |
|
46% |
|
|
20 |
| 8 |
8/9/2001 |
|
10.1 |
|
5,300 |
48% |
|
44% |
|
|
20 |
| 9 |
9/19/2001 |
|
11.3 |
|
5,800 |
53% |
|
42% |
2436 |
31% |
43 |
| 10 |
10/12/2001 |
|
10.5 |
|
5,500 |
50% |
|
44% |
|
|
25 |
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
M |
9 |
160,000 |
2,600 |
60% |
1,560 |
38% |
988 |
|
|
| 1 |
|
|
14.7 |
200,000 |
5,000 |
57% |
2,850 |
38% |
1,900 |
|
|
| 9 |
|
|
10 |
130,000 |
6,000 |
40% |
2,400 |
55% |
3,300 |
45% |
|
| Months After Present |
Patient
'K' |
Patient
'L' |
Patient
'H' |
Patient
'B' |
Patient
'N' |
|
| Hb/PCV |
Lymphocyte
Count |
M.P |
Hb/PCV |
Lymphocyte
Count |
M.P |
Hb/PCV |
Lymphocyte
Count |
M.P |
Hb/PCV |
Lymphocyte
Count |
M.P |
Hb/PCV |
Lymphocyte
Count |
M.P |
| |
| 1 |
(10/32) |
52 |
(+ve) |
(9.8/30) |
32 |
|
(6.5/20) |
54 |
(+ve) |
(11.6/32) |
44 |
(+ve) |
(15.0/48) |
40 |
(+ve) |
| 2 |
|
|
|
(8.5/25) |
34 |
|
(8.0/25) |
50 |
(+ve) |
|
|
|
|
|
|
| 3 |
(10/32) |
42 |
(+ve) |
(9.5/30) |
48 |
|
(9.0/28) |
50 |
(-ve) |
(10.0/30) |
56 |
(+ve) |
(9.0/29) |
44 |
(-ve) |
| 4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5 |
(8.5/27) |
35 |
(+ve) |
|
|
|
|
Notice:
Improved imunity in These HIV/AIDS Patients Being Treated With
Salvage A and Salvage B.
M.P. Often Disappears with improved immunity. |
|
|
| 6 |
|
|
|
(9.5/30) |
46 |
|
|
|
|
| 7 |
(9.6/30) |
44 |
(-ve) |
|
|
|
|
|
|
| 8 |
|
|
|
(10.1/30) |
44 |
|
|
|
|
|
|
|
|
|
|
| 9 |
(10/33) |
65 |
(-ve) |
( /34) |
42 |
|
|
|
|
|
|
|
|
|
|
| 10 |
|
|
|
( /35) |
34 |
|
|
M.P. =
Malaria parasite is a feature of HIV/AIDS Patients in West
Africa. Increased Malaria Attacks May Indicate compromised
immunity |
|
|
| 11 |
|
|
|
( /33) |
44 |
|
|
|
|
| 12 |
(12/37) |
48 |
(-ve) |
|
|
|
|
|
|
| 13 |
|
|
|
|
|
|
|
|
|
| |
|